📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Isoniazid resistance-conferring mutations are associated with highly variable phenotypic resistance. (2023)

First Author: Lale Ngema S

Attributed to: Addressing challenges in scaling up TB and HIV treatment integration in public health settings in South Africa funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jctube.2023.100387

PubMed Identifier: 37554582

Publication URI: http://europepmc.org/abstract/MED/37554582

Type: Journal Article/Review

Volume: 33

Parent Publication: Journal of clinical tuberculosis and other mycobacterial diseases

ISSN: 2405-5794